Eli Lilly Corp. buy The Goldman Sachs Group, Inc.
Start price
04.02.26
/
50%
€912.10
Target price
04.02.27
-
Performance (%)
-12.69%
Price
30.04.26
€796.40
Summary
This prediction is currently active. The price of Eli Lilly Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.69%. This prediction currently runs until 04.02.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 1.439% | 1.439% |
| iShares Core DAX® | 0,99 % | 8,31 % |
| iShares Nasdaq 100 | 2,07 % | 16,77 % |
| iShares Nikkei 225® | 2,27 % | 15,61 % |
| iShares S&P 500 | 1,04 % | 11,08 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for LLY provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€881.10
13.12.25
13.12.25
€975.54
13.12.26
13.12.26
-9.61%
30.04.26
30.04.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€719.00
12.10.25
12.10.25
€756.64
12.10.26
12.10.26
10.77%
30.04.26
30.04.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€678.00
08.04.25
08.04.25
€810.30
08.04.26
08.04.26
20.34%
09.04.26
09.04.26